AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $846,317 | +108.5% | 14,143 | -2.1% | 0.01% | +100.0% |
Q3 2019 | $405,985 | -16.6% | 14,453 | +12.5% | 0.01% | -12.5% |
Q2 2019 | $486,501 | -0.7% | 12,850 | +2.3% | 0.01% | -11.1% |
Q1 2019 | $489,935 | +83.0% | 12,556 | 0.0% | 0.01% | +80.0% |
Q4 2018 | $267,694 | -36.1% | 12,556 | +18.6% | 0.01% | -28.6% |
Q3 2018 | $419,060 | -99.9% | 10,585 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $404,453,000 | +135.8% | 10,585 | +85.4% | 0.01% | +250.0% |
Q1 2018 | $171,526,000 | +96262.9% | 5,708 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $178,000 | -44.7% | 5,708 | -50.4% | 0.00% | 0.0% |
Q3 2017 | $322,000 | +46.4% | 11,499 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $220,000 | – | 11,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |